Organs-on-a-chip (OOCs) are microfluidic devices that replicate the structure and function of human organs in vitro on a small scale. These devices consist of microfabricated chambers, channels, and compartments that simulate the microarchitecture and physiological environment of specific organs, enabling the study of organ-level responses to drugs, toxins, and diseases in a controlled laboratory setting. Each organ-on-a-chip device is designed to mimic the key features of a particular organ or tissue, such as the lung, liver, heart, intestine, kidney, or brain. By incorporating living cells, extracellular matrix components, and fluid flow systems into the device, OOCs can reproduce the complex interactions between different cell types, the mechanical forces experienced by cells in vivo, and the dynamic transport of nutrients, oxygen, and signalling molecules within the organ. One of the key advantages of organs-on-a-chip is their ability to recapitulate the physiological and pathological responses of human organs more accurately than traditional 2D cell culture systems or animal models. OOCs provide a more relevant platform for drug screening, toxicity testing, and disease modelling, as they better mimic the cellular microenvironment, tissue architecture, and functional properties of human organs.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States